Advertisement

Topics

Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc. Company Profile

01:56 EDT 23rd October 2018 | BioPortfolio

Founded in 2000, Cambrooke is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy. More information is available at www.cambrooke.com.


News Articles [788 Associated News Articles listed on BioPortfolio]

Introducing Glytactin BUILD 20/20™ and Glytactin RTD Lite: The Lowest Phe GMP PKU Formulas Ever

Cambrooke Therapeutics Inc., a leader in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy, announces its latest breakthrough in Phenylketonuria (PK...

Ajinomoto Althea and OmniChem Integrate

Businesses and operations will integrate as a unified CDMO, and will operate as Ajinomoto Bio-Pharma Services

Ajinomoto Althea opens new manufacturing facility in San Diego

Ajinomoto Altheaâs new ADC and highly potent fill and finish facility in San Diego supports early clinical phase through commercially approved programs.

Ajinomoto announces 10% price increase on amino acid portfolio

Ajinomotoâs amino acid technologies division announced a 10% price increase across all of its markets due to rising causes of manufacturing and transportation.

Ajinomoto Health & Nutrition's Amino Acid Division Announces Price Increase

Market Conditions Increase Production Costs RALEIGH, N.C. (PRWEB) October 05, 2018 The Amino Acid Technologies Division of Ajinomoto Health and Nutrition North America, Inc. (AHN), is announcing a 10...

Filament BioSolutions, Ajinomoto in Devt. Collaboration

Filament is expanding its product pipeline to include multiple oncology co-therapies

Ajinomoto Althea Makes Key VP Hires

Bert Barbosa to serve as VP of Drug Product Manufacturing , and Darwin Richardson, MBA to serve as VP of Compliance

Technical Perspectives on Biotech Stocks -- Adaptimmune Therapeutics, Akebia Therapeutics, ...

www.wallstequities.com/registration Adaptimmune Therapeutics Shares in Abingdon, the UK headquartered Adaptimmune Therapeutics PLC rose slightly by 0.41%, ending Wednesday's trading session at $12...

PubMed Articles [446 Associated PubMed Articles listed on BioPortfolio]

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

Pharmacokinetic Analysis of Intraocular Penetration of Latanoprost Solutions with Different Preservatives in Human Eyes.

Eyes on New Product Development: Preclinical Research.

Clinical Trials [158 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1274 Associated Companies listed on BioPortfolio]

Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc.

Founded in 2000, Cambrooke is a Massachusetts-based therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medic...

Ajinomoto Co. (H.K.) Ltd

Ajinomoto Co.Inc, is a global corporation in Food and Amino Acid Products. With headquarters in Japan, AJINOMOTO has operations over 23 countries and regions, including 108 manufacturing plants in 15 ...

Ajinomoto Co., Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto has con...

Ajinomoto Company, Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto has con...

Ajinomoto North America, Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto has con...

More Information about "Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc." on BioPortfolio

We have published hundreds of Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc. news stories on BioPortfolio along with dozens of Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc. Clinical Trials and PubMed Articles about Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc. Companies in our database. You can also find out about relevant Cambrooke Therapeutics, Inc. and Ajinomoto Co. Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...


Corporate Database Quicklinks



Searches Linking to this Company Record